Bissan Al-Lazikani
Affiliations: | Cancer Therapeutics Unit | The Institute of Cancer Research |
Google:
"Bissan Al-Lazikani"Parents
Sign in to add mentorChildren
Sign in to add trainee| Krishna C. Bulusu | grad student | The Institute of Cancer Research | |
| Elizabeth A Coker | grad student | 2012-2016 | The Institute of Cancer Research |
| Albert A. Antolín | post-doc | The Institute of Cancer Research (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sanfelice D, Antolin AA, Crisp A, et al. (2024) The Chemical Probes Portal - 2024: update on this public resource to support best-practice selection and use of small molecules in biomedical research. Nucleic Acids Research |
| Gingrich PW, Chitsazi R, Biswas A, et al. (2024) canSAR 2024-an update to the public drug discovery knowledgebase. Nucleic Acids Research |
| Neeb A, Figueiredo I, Bogdan D, et al. (2024) Thio-2 inhibits key signaling pathways required for the development and progression of castration resistant prostate cancer. Molecular Cancer Therapeutics |
| di Micco P, Antolin AA, Mitsopoulos C, et al. (2023) canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research. 51: D1212-D1219 |
| Antolin AA, Sanfelice D, Crisp A, et al. (2022) The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use. Nucleic Acids Research |
| Dolciami D, Villasclaras-Fernandez E, Kannas C, et al. (2022) canSAR chemistry registration and standardization pipeline. Journal of Cheminformatics. 14: 28 |
| Coker EA, Stewart A, Ozer B, et al. (2022) Individualised prediction of drug response and rational combination therapy in NSCLC using artificial intelligence enabled studies of acute phosphoproteomic changes. Molecular Cancer Therapeutics |
| Müller S, Ackloo S, Al Chawaf A, et al. (2021) Target 2035 - update on the quest for a probe for every protein. Rsc Medicinal Chemistry. 13: 13-21 |
| Antolin AA, Clarke PA, Collins I, et al. (2021) Evolution of kinase polypharmacology across HSP90 drug discovery. Cell Chemical Biology |
| Mitsopoulos C, Di Micco P, Fernandez EV, et al. (2020) canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research |